Motor unit number index correlates with disability in Charcot-Marie-Tooth disease

Ahn, 2010, Reproducibility of the motor unit number index (MUNIX) in normal controls and amyotrophic lateral sclerosis patients, Muscle Nerve, 42, 808, 10.1002/mus.21765 Armon, 1999, Motor unit number estimate-based rates of progression of ALS predict patient survival, Muscle Nerve, 22, 1571, 10.1002/(SICI)1097-4598(199911)22:11<1571::AID-MUS13>3.0.CO;2-0 Attarian, 2014, An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A, Orphanet J. Rare Dis, 9, 199, 10.1186/s13023-014-0199-0 Barreto, 2016, Epidemiologic study of charcot-marie-tooth disease: a systematic review, Neuroepidemiology, 46, 157, 10.1159/000443706 Boekestein, 2012, Motor unit number index (MUNIX) versus motor unit number estimation (MUNE): a direct comparison in a longitudinal study of ALS patients, Clin Neurophysiol Off J Int Fed, 123, 1644, 10.1016/j.clinph.2012.01.004 Burns, 2009, Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial, Lancet Neurol, 8, 537, 10.1016/S1474-4422(09)70108-5 Chumakov, 2014, Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy, Orphanet J Rare Dis, 9, 201, 10.1186/s13023-014-0201-x Colomban, 2014, Clinical spectrum and gender differences in a large cohort of Charcot-Marie-Tooth type 1A patients, J Neurol Sci, 336, 155, 10.1016/j.jns.2013.10.029 Delmont, 2016, Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?, Clin Neurophysiol Off J Int Fed, 127, 1891, 10.1016/j.clinph.2015.12.002 Escorcio-Bezerra, 2016, MUNIX: Reproducibility and clinical correlations in Amyotrophic Lateral Sclerosis, Clin Neurophysiol Off J Int Fed, 127, 2979, 10.1016/j.clinph.2016.06.011 Fathi, 2016, Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): Long-term changes and reproducibility, Clin Neurophysiol Off J Int Fed, 127, 1984, 10.1016/j.clinph.2015.12.023 Furtula, 2013, MUNIX and incremental stimulation MUNE in ALS patients and control subjects, Clin Neurophysiol Off J Int Fed, 124, 610, 10.1016/j.clinph.2012.08.023 Graham, 2006, A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale, J Neurol Neurosurg Psychiatry, 77, 973, 10.1136/jnnp.2005.081547 Grimaldi, 2017, Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis, Muscle Nerve, 10.1002/mus.25595 Kochański, 2005, Molecular genetics studies in Polish Charcot-Marie-Tooth families, Folia Neuropathol, 43, 65 Krajewski, 2000, Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A, Brain J Neurol, 123, 1516, 10.1093/brain/123.7.1516 Lawson, 2003, Assessment of axonal loss in Charcot-Marie-Tooth neuropathies, Exp Neurol, 184, 753, 10.1016/S0014-4886(03)00293-0 Lewis, 2003, Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease, Muscle Nerve, 28, 161, 10.1002/mus.10419 Lewis, 2013, High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial, JAMA Neurol, 70, 981, 10.1001/jamaneurol.2013.3178 Mandel, 2015, A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment, Orphanet J Rare Dis, 10, 74, 10.1186/s13023-015-0293-y Manganelli, 2016 Micallef, 2009, Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial, Lancet Neurol, 8, 1103, 10.1016/S1474-4422(09)70260-1 Murphy, 2011, Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease, J Peripher Nerv Syst JPNS, 16, 191, 10.1111/j.1529-8027.2011.00350.x Nandedkar, 2011, Reproducibility of MUNIX in patients with amyotrophic lateral sclerosis, Muscle Nerve, 44, 919, 10.1002/mus.22204 Nandedkar, 2010, Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease, Muscle Nerve, 42, 798, 10.1002/mus.21824 Nandedkar, 2004, Motor unit number index (MUNIX), IEEE Trans Biomed Eng, 51, 2209, 10.1109/TBME.2004.834281 Neuwirth, 2015, Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): a 15-month longitudinal multicentre trial, J Neurol Neurosurg Psychiatry, 86, 1172, 10.1136/jnnp-2015-310509 Neuwirth, 2016, Quality control of motor unit number index (MUNIX) measurements in 6 muscles in a single-subject “Round-Robin” Setup, PloS One, 11, e0153948, 10.1371/journal.pone.0153948 Neuwirth, 2011, Motor Unit Number Index (MUNIX): a novel neurophysiological marker for neuromuscular disorders; test-retest reliability in healthy volunteers, Clin Neurophysiol Off J Int Fed, 122, 1867, 10.1016/j.clinph.2011.02.017 Otto M, Markvardsen L, Tankisi H, Jakobsen J, Fuglsang-Frederiksen A. The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Acta Neurol. Scand. doi:10.1111/ane.12663 2016. Paramanathan, 2016, Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX, Clin Neurophysiol Off J Int Fed, 127, 898, 10.1016/j.clinph.2015.05.004 Pareyson, 2009, Diagnosis, natural history, and management of Charcot-Marie-Tooth disease, Lancet Neurol, 8, 654, 10.1016/S1474-4422(09)70110-3 Pareyson, 2011, Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial, Lancet Neurol, 10, 320, 10.1016/S1474-4422(11)70025-4 Pareyson, 2006, Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease, Neuromolecular Med, 8, 3, 10.1385/NMM:8:1-2:3 Patzkó, 2011, Update on Charcot-Marie-Tooth disease, Curr Neurol Neurosci Rep, 11, 78, 10.1007/s11910-010-0158-7 Philibert, 2017, Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index, Clin Neurophysiol Off J Int Fed, 128, 235, 10.1016/j.clinph.2016.11.012 Shefner, 2001, Motor unit number estimation in human neurological diseases and animal models, Clin Neurophysiol Off J Int Fed, 112, 955, 10.1016/S1388-2457(01)00520-X Stein, 2016, Toward the validation of a new method (MUNIX) for motor unit number assessment, J Electromyogr Kinesiol Off J Int Soc Electrophysiol Kinesiol, 27, 73, 10.1016/j.jelekin.2016.02.001 Szigeti, 2009, Charcot-Marie-Tooth disease, Eur J Hum Genet EJHG, 17, 703, 10.1038/ejhg.2009.31 van Nes, 2011, Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies, Neurology, 76, 337, 10.1212/WNL.0b013e318208824b Verhamme, 2009, Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial, BMC Med, 7, 70, 10.1186/1741-7015-7-70 Verhamme, 2004, Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia, J Neurol, 251, 1491, 10.1007/s00415-004-0578-x Videler, 2008, Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a, Neurology, 71, 1254, 10.1212/01.wnl.0000327643.05073.eb